bioRxiv Science⌕ Search

Biology subjects

Leong, T. L.

Publications and source records attributed to Leong, T. L..

2 recordsLinked to original sources

Optogenetic construction of de novo integrin-adhesion complexes reveals role for biocondensation in adhesion nucleation

Integrin-adhesion complexes (IACs) form spontaneously in cells on extracellular matrix substrates, allowing them to sense matrix composition and transduce force. However, IACs often do not form uniformly across a cell, which begs the question: What is required to nucleate an adhesion, and what factors enable the stabilization of an IAC once it has formed? Many factors have been suggested to promote formation and the subsequent stabilization of IACs. It is difficult to explicitly test these factors in vivo as IACs undergo constant remodeling. Here, we employ optogenetics to explicitly test the ability of talin in different activity and phase states to nucleate and stabilize IACs in regions where none are present. We find that fusion of intrinsically disordered regions directly to talin enhances its adhesion nucleation potential and allows new adhesions to be produced in response to optogenetic talin clustering. Similarly, expression of factors previously shown to enhance biocondensation in vitro, such as paxillin, the paxillin N-terminus, or unfolding of talin, allows for adhesion nucleation and biocondensation of talin. We show that these biocondensates of talin can cluster and activate integrins even in the absence of extracellular matrix. By applying optogenetic activation to regions of the cell with or without ventral actomyosin, we demonstrate actomyosin engagement promotes the formation and stability of adhesions. These results are corroborated by theoretical modelling which shows that phase separation of talin is enhanced by differential clutch formation in the presence of actomyosin thus enabling peripheral adhesion formation and stability. This work establishes a model in which increased cooperativity of talin enables IAC nucleation through talin biocondensation, which clusters and activates integrins. In addition to these findings, we generate multiple optogenetic tools that enable local nucleation or enhancement of IACs. HighlightsO_LIOptogenetic tools mediating talin biocondensation can locally induce focal adhesion formation C_LIO_LIPaxillin LD domains enable biocondensation of talin C_LIO_LIBiocondensation of talin enables IAC formation C_LIO_LIPhase separation of talin can activate integrins independently of ECM C_LIO_LIComputational model reconciles spatial variance in LLPS and IAC formation. C_LI

cell biology↗

γδ T cells modulate anti-tumor immunity in small cell lung cancer

Small cell lung cancer (SCLC) is a highly aggressive neoplasm with limited sensitivity to anti-PD-(L)1 blockade, likely due to the epigenetic silencing of MHC-I. Elucidating MHC-I-independent immune recognition mechanisms is therefore crucial for enhancing treatment responses and improving clinical outcomes in a greater number of patients. Leveraging single cell approaches, we discovered {gamma}{delta} T cell infiltration in biospecimens from patients with SCLC. Despite PD-1 expression, {gamma}{delta} T cells maintained a cytotoxic transcriptional profile, suggestive of an anti-tumor role. Indeed, high {gamma}{delta} T cell infiltration predicted improved response to anti-PD-L1 immunotherapy in patients with SCLC. Moreover, using pre-clinical models, we demonstrated that {gamma}{delta} T cells are effective at tarlatamab (DLL3-CD3 BiTE) redirected SCLC killing and that zoledronate, an FDA-approved compound, can sensitize SCLC cells to {gamma}{delta} T cell-mediated killing. Thus, our findings suggest that engaged {gamma}{delta} T cells are potentially valuable targets for SCLC therapy.

cancer biology↗